25582-47-2

Upstream product

• 15761-39-4 1-(tert-butoxycarbonyl)-L-proline 
• 2768-50-5 dibenzyl L-glutamate 

Downstream Products

• 842120-78-9 dibenzyl N,N-dimethylglycyl-L-proline-L-glutamate 
• 842120-82-5 dibenzyl pyrrolidinoglycyl-L-prolyl-L-glutamate 
• 842120-87-0 dibenzyl piperidinoglycyl-L-prolyl-L-glutamate 
• 842120-76-7 dibenzyl N-benzyloxycarbonyl-N-methylglycyl-L-proline-L-glutamate 
• 842120-63-2 (S)-2-{[(S)-1-((S)-2-Benzyloxycarbonylamino-propionyl)-pyrrolidine-2-carbonyl]-amino}-pentanedioic acid dibenzyl ester 
• 842120-61-0 (S)-2-{[(S)-1-((R)-2-Benzyloxycarbonylamino-propionyl)-pyrrolidine-2-carbonyl]-amino}-pentanedioic acid dibenzyl ester 
• 842120-90-5 dibenzyl N-benzyloxycarbonyl-β-alanyl-L-prolyl-L-glutamate 
• 842120-60-9 L-proline-L-glutamic acid dibenzyl ester 

Relevant academic research and scientific papers

TREATMENT OF AUTISM SPECTRUM DISORDERS USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID

This invention provides compounds, compositions and methods for treating Autism Spectrum Disorders (ASD) using glycyl-2-methyIprolyl-glutamic acid (G-2-MePE) and analogs thereof. Autism Spectrum Disorders include Autism, Autistic Disorder, Asperger Syndro

TREATMENT OF AUTISM SPECTRUM DISORDERES USING GLYCYL-L-2-METHYLPROLYL-L-GLUTAMIC ACID

This invention provides compounds, compositions and methods for treating Autism Spectrum Disorders (ASD) using glycyl-2-methylprolyl-glutamic acid (G-2-MePE) and analogs thereof. Autism Spectrum Disorders include Autism, Autistic Disorder, Asperger Syndro